Merck & Co., Inc. Cash Equivalents, at Carrying Value
Merck & Co., Inc. (MRK) had Cash Equivalents, at Carrying Value of $10.90 billion as of 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashEquivalentsAtCarryingValue · last filed 2017-05-09
- 2017-03-31: Cash Equivalents, at Carrying Value $10.90B.
- 2016-09-30: Cash Equivalents, at Carrying Value $7.20B.
- 2016-06-30: Cash Equivalents, at Carrying Value $6.00B.
- 2016-03-31: Cash Equivalents, at Carrying Value $8.90B.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2017-03-31 | $10.90B 10-Q · filed 2017-05-09 |
| 2016-09-30 | $7.20B 10-Q · filed 2016-11-07 |
| 2016-06-30 | $6.00B 10-Q · filed 2016-08-08 |
| 2016-03-31 | $8.90B 10-Q · filed 2016-05-09 |
| 2015-09-30 | $6.50B 10-Q · filed 2015-11-05 |
| 2015-06-30 | $5.90B 10-Q · filed 2015-08-06 |
| 2015-03-31 | $6.60B 10-Q · filed 2015-05-07 |
| 2014-09-30 | $10.40B 10-Q · filed 2014-11-10 |
| 2014-06-30 | $8.70B 10-Q · filed 2014-08-07 |
| 2014-03-31 | $14.70B 10-Q · filed 2014-05-08 |
| 2013-09-30 | $13.10B 10-Q · filed 2013-11-07 |
| 2013-06-30 | $14.30B 10-Q · filed 2013-08-07 |
| 2013-03-31 | $12.00B 10-Q · filed 2013-05-09 |
| 2012-12-31 | $12.50B 10-K · filed 2013-02-28 |
| 2012-09-30 | $16.60B 10-Q · filed 2012-11-09 |
| 2012-06-30 | $15.90B 10-Q · filed 2012-08-07 |
| 2012-03-31 | $13.90B 10-Q · filed 2012-05-08 |
| 2011-12-31 | $12.70B 10-K · filed 2012-02-28 |
| 2011-09-30 | $13.30B 10-Q · filed 2011-11-08 |
| 2011-06-30 | $11.80B 10-Q · filed 2011-08-08 |
| 2011-03-31 | $11.00B 10-Q · filed 2011-05-09 |
| 2010-12-31 | $10.30B 10-K · filed 2011-02-28 |
| 2010-09-30 | $9.20B 10-Q · filed 2010-11-08 |
| 2010-06-30 | $7.90B 10-Q · filed 2010-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |